1. Semi-synthesis, structural modification and biological evaluation of 5-arylbenzofuran neolignans
   Ding Lin et al, 2018, RSC Advances CrossRef
2. Recent Advancements in the Discovery of MDM2/MDM2-p53 Interaction Inhibitors for the Treatment of Cancer
   Neha Bhatia et al, 2023, Current Medicinal Chemistry CrossRef
3. Quinalizarin exerts an anti-tumour effect on lung cancer A549 cells by modulating the Akt, MAPK, STAT3 and p53 signalling pathways
   Ling‑Qi Meng et al, 2017, Molecular Medicine Reports CrossRef
4. Quercetin Promotes Cell Cycle Arrest and Apoptosis and Attenuates the Proliferation of Human Chronic Myeloid Leukemia Cell Line-K562 Through Interaction with HSPs (70 and 90), MAT2A and FOXM1
   Ali Hassanzadeh et al, 2019, Anti-Cancer Agents in Medicinal Chemistry CrossRef
5. Applying genome-wide CRISPR to identify known and novel genes and pathways that modulate formaldehyde toxicity
   Yun Zhao et al, 2021, Chemosphere CrossRef
6. Molecular Mechanisms of Antiproliferative Effects of Natural Chalcones
   Radka Michalkova et al, 2021, Cancers CrossRef
7. Kalkon Türevlerinin Antikanser Mekanizmaları
   Yaren YILDIZ et al, 2023, Iğdır Üniversitesi Fen Bilimleri Enstitüsü Dergisi CrossRef
8. Antitumor Effects of Blocking Protein Neddylation in T315I-BCR-ABL Leukemia Cells and Leukemia Stem Cells
   Chang Liu et al, 2018, Cancer Research CrossRef
9. Melanoma Cancer Immunotherapy Using PD-L1 siRNA and Imatinib Promotes Cancer-Immunity Cycle
   Chenyang Li et al, 2020, Pharmaceutical Research CrossRef
10. In the Pipeline: Emerging Therapy for CML
    Harinder Gill et al, 2023, Pathogenesis and Treatment of Leukemia CrossRef
11. Two novel 1,4‑naphthoquinone derivatives induce human gastric cancer cell apoptosis and cell cycle arrest by regulating reactive oxygen species‑mediated MAPK/Akt/STAT3 signaling pathways
    Hao Wang et al, 2019, Molecular Medicine Reports CrossRef
12. Oridonin increases anticancer effects of lentinan in HepG2 human hepatoblastoma cells
    Zhiqiang Sun et al, 2017, Oncology Letters CrossRef
13. Oridonin enhances in vitro anticancer effects of lentinan in SMMC‑7721 human hepatoma cells through apoptotic genes
    Tao Xu et al, 2017, Experimental and Therapeutic Medicine CrossRef
14. Persistent STAT5-mediated ROS production and involvement of aberrant p53 apoptotic signaling in the resistance of chronic myeloid leukemia to imatinib
    Yanhong Cheng et al, 2017, International Journal of Molecular Medicine CrossRef
15. p53 Gene (NY-CO-13) Levels in Patients with Chronic Myeloid Leukemia: The Role of Imatinib and Nilotinib
    Hayder Al-kuraishy et al, 2018, Diseases CrossRef
16. Leukemia therapy by flavonoids: Future and involved mechanisms
    Raedeh Saraei et al, 2019, Journal of Cellular Physiology CrossRef
17. Discovery of Novel SIRT1/2 Inhibitors with Effective Cytotoxicity against Human Leukemia Cells
    Haiyan Cai et al, 2023, Journal of Chemical Information and Modeling CrossRef
18. Molecular mechanisms underlying chemopreventive potential of butein: Current trends and future perspectives
    Hardeep Singh Tuli et al, 2021, Chemico-Biological Interactions CrossRef
19. Butein inhibits NF-κB, AP-1 and Akt activation in adult T-cell leukemia/lymphoma
    Chie Ishikawa et al, 2017, International Journal of Oncology CrossRef
20. Butein in health and disease: A comprehensive review
    Ganesan Padmavathi et al, 2017, Phytomedicine CrossRef
21. Flavonoid-Based Cancer Therapy: An Updated Review
    Elham Hosseinzadeh et al, 2020, Anti-Cancer Agents in Medicinal Chemistry CrossRef
22. Bioactive Phytoconstituents and Their Therapeutic Potentials in the Treatment of Haematological Cancers: A Review
    Emeka J. Iweala et al, 2023, Life CrossRef
23. Small‐molecule MDM2 inhibitor LQFM030‐induced apoptosis in p53‐null K562 chronic myeloid leukemia cells
    Higor de Oliveira Ribeiro et al, 2020, Fundamental & Clinical Pharmacology CrossRef